glp-1 and beta blockers Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management Current Insights, Advantages and Challenges

Middle age is a critical period for diet-induced cognitive decline (1214), coinciding with the menopausal transition in females

Accordingly, GLP-1RAs have been increasingly used in the treatment of PCOS because of their ability to reduce weight and improve IR (155159)

These medications have seen an explosion in sales with the approval and off-label use for weight loss, typically resulting in a reduction in body weight of 15-21% when combined with nutrition and exercise

Stopping abruptly after just a few weeks might not show clear results, so give it time to work or just reduce the dosage with Glutone C or Glutone MD for maintenance

Consequently, voluntary adoption and industry-driven solutions have been the main avenue for drug ePA thus far

The main cerebral target for THC is type-1 cannabinoid receptors (CB1R), which are widely expressed in the brain and regulate various functions including neurotransmitter release, neuro-astroglial communication, and cellular bioenergetic processes [29,30,31,32]